Cradeon was established in Jakarta with a single operational premise: that a daily supplement for men should reflect the same documentation discipline applied to any other precision nutritional input. Not a product shaped by marketing objectives, but one anchored in published nutritional science and verifiable supplier data.
The formulation team at Cradeon brings a background in nutritional science and food-grade production standards. All decisions regarding ingredient selection, supplier qualification, and batch verification are made by qualified nutrition professionals, not marketing departments.
The decision to establish Cradeon came from a straightforward observation: the majority of commercially available men's supplements in the Indonesian market lack accessible batch documentation. A customer purchasing a daily vitamin complex has, in most cases, no means of verifying the elemental concentration of what is on the label against an independent laboratory result.
Cradeon was built around a documentation-first approach. The formulation specification is written before the production run, not after. The independent batch verification certificate is obtained before the product is released for distribution, not as an afterthought.
This is not a marketing claim. It is a description of the operational sequence — one that can be verified by requesting the current batch documentation from the team at [email protected].
Documentation Available
Each Cradeon batch is accompanied by a certificate of composition from an independent laboratory. Certificates are archived by batch code and available upon written request to the Cradeon team.
The formulation process began with a structured review of published nutritional literature on adult male micronutrient intake patterns. Sources included EFSA scientific opinions, peer-reviewed nutritional journals, and dietary reference data from multiple regulatory authorities. The review identified a set of consistently underrepresented minerals and vitamins in the documented dietary patterns of adult men in tropical climates.
Following the literature review, a supplier identification process was conducted. Candidate suppliers were assessed on the basis of origin documentation, chain-of-custody records, and facility processing standard certifications. Only suppliers whose facilities maintain food-grade processing standards were approved for inclusion in the Cradeon supplier registry. The registry is maintained as a living document and reviewed annually.
With the supplier registry established, the formulation team drafted the composition specification for each Cradeon product. Quantities for each ingredient were derived from EU Nutrient Reference Values and contextualised against the dietary reference intakes used in the Indonesian regulatory framework. Each composition was reviewed against the stop-list of known interaction pairs before finalisation. The specification document is versioned and archived.
The first production run was conducted at a Jakarta facility operating under food-grade processing standards. Samples from the run were forwarded to an independent laboratory for elemental concentration analysis. The resulting certificate was compared against the specification document, and minor calibration adjustments were made to the blending sequence before the product was approved for release. This process is repeated for every subsequent batch.
DOCUMENTATION FIRST
No production commences before the formulation specification is finalised. No batch is released before the independent certificate is received and reviewed. The sequence is non-negotiable.
LITERATURE-INFORMED
Every ingredient selection is referenced to a specific publication. The Cradeon formulation file contains citations for each compositional decision. No ingredient is included on the basis of marketing convention alone.
TRACEABLE SOURCING
Each ingredient in the Cradeon composition is sourced from suppliers registered in the Cradeon supplier registry. Chain-of-custody documentation is maintained from supplier intake to finished product release. Origin data is available upon request.
CALIBRATED QUANTITIES
Quantities in the Cradeon composition are calibrated within published dietary reference value ranges. The aim is a nutritionally coherent daily measure — not a maximum-dosage supplement driven by shelf appeal.
The Cradeon formulation team comprises qualified nutrition professionals with backgrounds in food science, nutritional biochemistry, and food-grade manufacturing. No single individual background dominates the formulation process; the team operates as a peer-review structure where each composition decision is documented and reviewed before implementation.
The team does not include practitioners in any other discipline. Cradeon does not position its staff as advisors on individual health circumstances. For questions regarding suitability of any supplement for a specific dietary context, we recommend consultation with a qualified wellness or nutrition professional.
The Jakarta facility where Cradeon production occurs is operated by a separate production partner whose facility documentation is reviewed annually by the Cradeon formulation team. A copy of the current facility review summary is available upon written request.
SPECIALIST BACKGROUND
Nutritional biochemistry and food-grade manufacturing documentation
REVIEW STRUCTURE
Peer-reviewed formulation decisions, versioned and archived by batch code
LABORATORY PARTNERS
Independent third-party laboratories with no commercial relationship to Cradeon's production
REGULATORY FILING
Products registered as food-supplements under applicable Indonesian regulatory framework
Incoming ingredients are tested against the specification limits prior to production. Lots failing specification are returned to the supplier with a documented rejection record.
During blending and encapsulation, in-line samples are taken at defined intervals. Samples are retained in the batch archive for a minimum of twenty-four months post-production.
The finished capsule lot is submitted to an independent laboratory for elemental analysis and contaminant screening. The resulting certificate is the primary release authorisation document.
The complete formulation specification, supplier registry summary, and current batch certificate are available to qualified wellness professionals and researchers. Submit a written request to the Cradeon team.